Literature DB >> 20623383

Brief report: biomarkers of aortic vascular prosthetic graft infection in a porcine model with Staphylococcus aureus.

S N Langerhuus1, E K Tønnesen, K H Jensen, B M Damgaard, P M H Heegaard, U Halekoh, C Lauridsen.   

Abstract

Aortic vascular prosthetic graft infection (AVPGI) with Staphylococcus aureus is a feared post-operative complication. This study was conducted to evaluate the clinical signs and potential biomarkers of infection in a porcine AVPGI model. The biomarkers evaluated were: C-reactive protein (CRP), fibrinogen, white blood cells (WBC), major histocompatibility complex II (MHC II) density, lymphocyte CD4:CD8 ratio and tumour necrosis factor-alpha (TNF-α) in vitro responsiveness. Sixteen pigs were included in the study, and randomly assigned into four groups (n = 4): "SHAM" pigs had their infra-renal aorta exposed by laparotomy; "CLEAN" pigs had an aortic graft inserted; "LOW" and "HIGH" pigs had an aortic graft inserted and, subsequently, S. aureus were inoculated on the graft material (5 × 10(4) colony-forming units [CFU] and 1 × 10(6) CFU, respectively). Biomarkers were evaluated prior to surgery and on day 2, 5, 7, and 14 post-operatively in blood samples. Of all biomarkers evaluated, CRP was superior for diagnosing S. aureus AVPGI in pigs, with a sensitivity of 0.86 and a specificity of 0.75.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20623383     DOI: 10.1007/s10096-010-1008-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  9 in total

Review 1.  Prevention and treatment of aortic graft infection.

Authors:  Firas F Mussa; Nasim Hedayati; Wei Zhou; Hosam F El-Sayed; Panagiotis Kougias; Rabih O Darouiche; Peter H Lin
Journal:  Expert Rev Anti Infect Ther       Date:  2007-04       Impact factor: 5.091

2.  Monocyte function before and after surgical trauma.

Authors:  W Haupt; J Riese; C Mehler; K Weber; M Zowe; W Hohenberger
Journal:  Dig Surg       Date:  1998       Impact factor: 2.588

3.  Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T lymphocytes.

Authors:  J A D'Orazio; J Stein-Streilein
Journal:  Clin Exp Immunol       Date:  1996-05       Impact factor: 4.330

4.  Determination of tumor necrosis factor-alpha responsiveness in piglets around weaning using an ex vivo whole blood stimulation assay.

Authors:  Lone Carstensen; Christine Maria Røntved; Jens Peter Nielsen
Journal:  Vet Immunol Immunopathol       Date:  2005-05-01       Impact factor: 2.046

5.  A robust quantitative solid phase immunoassay for the acute phase protein C-reactive protein (CRP) based on cytidine 5'-diphosphocholine coupled dendrimers.

Authors:  Peter M H Heegaard; Heidi G Pedersen; Asger Lundorff Jensen; Ulrik Boas
Journal:  J Immunol Methods       Date:  2009-02-21       Impact factor: 2.303

6.  Laparoscopic diagnosis and treatment of aortic vascular prosthetic graft infections in a porcine model.

Authors:  H Gao; L Lund; J Prag; J Sandermann; J S Lindholt
Journal:  Eur J Vasc Endovasc Surg       Date:  2007-08-24       Impact factor: 7.069

Review 7.  Management of infected aortic prosthetic grafts.

Authors:  Timothy W Swain; Keith D Calligaro; Matthew D Dougherty
Journal:  Vasc Endovascular Surg       Date:  2004 Jan-Feb       Impact factor: 1.089

8.  Downregulation of proinflammatory cytokine release in whole blood from septic patients.

Authors:  W Ertel; J P Kremer; J Kenney; U Steckholzer; D Jarrar; O Trentz; F W Schildberg
Journal:  Blood       Date:  1995-03-01       Impact factor: 22.113

9.  Pre- and postoperative cytokine release after in vitro whole blood lipopolysaccharide stimulation and frequent toll-like receptor 4 polymorphisms.

Authors:  Oliver Kumpf; Lutz Hamann; Peter M Schlag; Ralf R Schumann
Journal:  Shock       Date:  2006-02       Impact factor: 3.454

  9 in total
  1 in total

Review 1.  Multidisciplinary Treatment Approach for Prosthetic Vascular Graft Infection in the Thoracic Aortic Area.

Authors:  Takeshiro Fujii; Yoshinori Watanabe
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-09-08       Impact factor: 1.520

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.